%0 Generic
%A Mirza, M. R.
%A Bjorge, L.
%A Marme, F.
%A Christensen, R. DePont
%A Gil-Martin, M.
%A Auranen, A.
%A Ataseven, B.
%A Rubio, M. J.
%A Salutari, V.
%A Lund, B.
%A Runnebaum, I.
%A Redondo, A.
%A Lindemann, K.
%A Trillsch, F.
%A Barretina Ginesta, M. P.
%A Roed, H.
%A Lohndorf, J.
%A Nyvang, G-B.
%A Sehouli, J.
%T A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/25337
%~